Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Influenza Vaccine
Immune responses to intranasal influenza vaccine determined
September 8th, 2004
Investigators have determined the mucosal and serum immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent influenza vaccine. "Influenza morbidity affects the entire population and has an enormous impact upon the economic burden and the health care systems. Available vaccines are often unsatisfactory and many individuals are reluctant to receive injections. Intranasal immunization is painless, side effect free, and may encourage a large number of individuals to participate in the vaccination programs. Ninety-two students were immunized intranasally once or twice, 21 days apart, with a...
Source: Vaccine Weekly (2004-09-08)
|
